DARZALEX FASPRO

Indicated For

multiple myeloma, amyloidosis

About This Medication

# Johnson & Johnson Patient Assistance Foundation (JJPAF) Patient Guide: How to Get DARZALEX FASPRO at Low or No Cost DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) is a prescription medication used to treat certain types of multiple myeloma, a blood cancer. The **Johnson & Johnson Patient Assistance Foundation (JJPAF)** program, offered by Janssen, provides this medicine at no cost to eligible uninsured patients who lack the financial resources to pay for it. This guide explains eligibility, application steps, and more to help you access treatment easily. ## About DARZALEX FASPRO DARZALEX FASPRO is an injectable medication given under the skin (subcutaneously) by a healthcare provider. It targets cancer cells in multiple myeloma, helping to slow disease progression, often used with other therapies. It's approved for adults with newly diagnosed or relapsed multiple myeloma. Common side effects include infusion reactions, fatigue, nausea, and infections—discuss risks with your doctor. Always follow your prescribed treatment plan[1][2]. ## Who Qualifies for JJPAF? The program targets **uninsured patients** in the US who cannot afford their Janssen medications, like DARZALEX FASPRO. You must: - Live in the US or a US territory. - Have no prescription insurance coverage. - Demonstrate financial need, typically through proof like tax returns. **Medicare Part D patients** may qualify if they spend more than 4% of gross annual household income on prescriptions and are not eligible for Low-Income Subsidy (LIS), especially if income is ≤150% FPL[2][6]. Insured patients generally do not qualify, though underinsured exceptions exist[8]. ## Income Eligibility Breakdown JJPAF does not publish fixed income thresholds like a percentage of the Federal Poverty Level (FPL). Instead, eligibility is based on overall financial resources, assessed case-by-case. Provide proof of income and assets to show you lack resources for medicines. | Household Size | Typical Income Consideration | Notes | |---------------|------------------------------|--------| | Individual | Assessed via tax return & assets | Must prove inability to pay; no strict limit | | Couple | Assessed via tax return & assets | Household income/assets reviewed | | Family of 3 | Assessed via tax return & assets | Include dependents on income | | Family of 4+ | Assessed via tax return & assets | Larger families may have more flexibility | Submit your most recent 1040 or 1040-SR tax return. Assets (e.g., savings, stocks) are factored in, excluding homes/vehicles[1][7]. For Puerto Rico, additional financial docs like Form 482 are needed[3]. ## Insurance Requirements You must be **uninsured**—no commercial, employer, Medicaid, or other prescription coverage. **Medicare Part D** patients: Submit pharmacy reports or Explanation of Benefits (EOB) showing out-of-pocket costs >4% of income[1][2]. Programs verify coverage first; changes in insurance disqualify you[7]. ## Step-by-Step Application Process 1. **Contact the Program**: Call **(800) 652-6227** or **833-742-0791** (Mon-Fri, 8 AM-8 PM ET) for help, or visit JJPatientAssistance.com[1][2]. 2. **Download the Form**: Get the Patient Assistance Enrollment Form from jnjwithme.com or the portal[1][3]. 3. **Complete Patient Section**: Fill in name, address, DOB, phone, email, income/assets, household size. Sign page 2, agreeing to terms. Review pages 4-7 (consent, authorization)—sign online if preferred at JJPatientAssistance.com/PA or /Consent[1][3]. 4. **Doctor Completes Page 3**: Your healthcare provider fills prescription details for DARZALEX FASPRO and signs (one per med)[1]. 5. **Gather Documents**: - Proof of residency (e.g., utility bill). - Proof of financial need (1040 tax return, income proof). - Prescription. - Insurance cards (front/back) if applicable, or Medicare EOB/pharmacy report[1][3]. 6. **Submit**: Fax to **1-833-512-0497**. Incomplete apps delay processing[1]. ## Timeline and Delivery Processing time varies (not specified), but complete submissions speed it up—expect updates via phone/email to you and your doctor[2]. Once approved, medication ships free to your home or doctor's office[program details]. **Reauthorization is required** annually or upon changes; notify within 30 days of income/insurance shifts[7]. ## Alternatives if Denied - **Appeal**: Call for reasons and resubmit missing docs[1]. - **Other Programs**: Check JNJwithMe.com for copay assistance if insured[4]. Medicare Extra Help/LIS for Part D[2]. Patient Access Network (PAN) Foundation or HealthWell Foundation for multiple myeloma. - **Simplefill**: Free service to match programs—call (877)386-0206[6]. - **State Assistance**: Local Medicaid or charity care. No biosimilar alternatives listed for DARZALEX FASPRO[program details]. ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026. Eligibility/rules can change—verify with JJPAF at (800) 652-6227 or jnjwithme.com. Not medical/financial advice; consult your doctor and advisor. Janssen/JJPAF denies liability for misuse. Report changes promptly to stay eligible[1][7]. (Word count: 942)

Program information last verified: March 30, 2026